Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carson

Showing results (571-580 of 918) with videos related to

Pageof 92
Sort By:
JACC. Heart Failure|June 6, 2015
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection FractionSøren L Kristensen, Pardeep S Jhund, Lars Køber, et al.
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2025
[<sup>18</sup>F]SynVesT-1 PET Detects SV2A Changes in the Spinal Cord and Brain of Rats with Spinal Cord InjuryBaosheng Chen, Chao Zheng, Tutukhanim Balayeva, et al.
JAMA Psychiatry|September 18, 2014
Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathologyRobert H Pietrzak, Mika Naganawa, Yiyun Huang, et al.
Molecular Psychiatry|March 1, 2017
In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependenceA T Hillmer, C M Sandiego, J Hannestad, et al.
Bioengineering & Translational Medicine|November 18, 2024
Pilot PET study of vaginally administered bioadhesive nanoparticles in cynomolgus monkeys: Kinetics and safety evaluationMolly K Grun, Praveen Honhar, Yazhe Wang, et al.
Biological Psychiatry|August 27, 2014
In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5Christine DeLorenzo, Nicole DellaGioia, Michael Bloch, et al.
Alcoholism, Clinical and Experimental Research|March 15, 2016
Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol AbstinenceAnsel T Hillmer, Tracy Kloczynski, Christine M Sandiego, et al.
Annals of Surgical Oncology|May 31, 2007
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanomaKimberly A Varker, Jennifer E Biber, Cheryl Kefauver, et al.
Pageof 92

Showing results (571-580 of 918) with videos related to

Sort By:
Pageof 92
JACC. Heart Failure|June 6, 2015
Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection FractionSøren L Kristensen, Pardeep S Jhund, Lars Køber, et al.
Circulation. Heart Failure|July 1, 2011
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trialInder S Anand, Thomas S Rector, John G Cleland, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2025
[<sup>18</sup>F]SynVesT-1 PET Detects SV2A Changes in the Spinal Cord and Brain of Rats with Spinal Cord InjuryBaosheng Chen, Chao Zheng, Tutukhanim Balayeva, et al.
JAMA Psychiatry|September 18, 2014
Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathologyRobert H Pietrzak, Mika Naganawa, Yiyun Huang, et al.
Molecular Psychiatry|March 1, 2017
In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependenceA T Hillmer, C M Sandiego, J Hannestad, et al.
Bioengineering & Translational Medicine|November 18, 2024
Pilot PET study of vaginally administered bioadhesive nanoparticles in cynomolgus monkeys: Kinetics and safety evaluationMolly K Grun, Praveen Honhar, Yazhe Wang, et al.
Biological Psychiatry|August 27, 2014
In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5Christine DeLorenzo, Nicole DellaGioia, Michael Bloch, et al.
Alcoholism, Clinical and Experimental Research|March 15, 2016
Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol AbstinenceAnsel T Hillmer, Tracy Kloczynski, Christine M Sandiego, et al.
Annals of Surgical Oncology|May 31, 2007
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanomaKimberly A Varker, Jennifer E Biber, Cheryl Kefauver, et al.
Pageof 92